SCHEMBL28899167

SCHEMBL28899167

COc1ccc(Cn2ccc3ccc(-n4cnc(C5CC5)c4)cc3c2=O)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
MAP3K5 Q99683 7/20 0.45
EGLN1 Q9GZT9 4/20 0.44
KLKB1 P03952 1/20 0.43
TP53 P04637 1/20 0.40
P2RX3 P56373 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30095514 1.00 HDAC3 (0.47) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL28899185 0.86 MAP3K5 (0.47) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL28899150 0.86 MAP3K5 (0.45) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL30095447 0.86 MAP3K5 (0.47) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL28899160 0.85 EGLN1 (0.38) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL30095357 0.85 EGLN1 (0.38) HDAC3HDAC1HDAC6MAP3K5EGLN1
SCHEMBL30095505 0.77 MAP3K5 (0.53) MAP3K5TP53
SCHEMBL28899151 0.77 MAP3K5 (0.53) MAP3K5TP53
SCHEMBL30362848 0.75 MAPT (0.42) MAP3K5ALDH1A1
SCHEMBL17801486 0.74 HDAC3 (0.59) HDAC3HDAC1HDAC6EGLN1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110294742-B Fused ring ASK1 inhibitor and application thereof 山东轩竹医药科技有限公司 2023-01-31 CN disclosed
CN-109456308-B Heterocyclic compounds as ASK inhibitors and their use 南京圣和药业股份有限公司 2022-11-29 CN disclosed
CN-109456308-A Heterocyclic compound and its application as ASK inhibitor 南京圣和药业股份有限公司 2019-03-12 CN disclosed